Fayad Al-Haimus: Key Themes from the New 2026 AHA/ACC Guideline for Acute PE
Fayad Al-Haimus, Adult Thrombosis Fellow at McMaster University, shared a post on LinkedIn about a recent article by Mark Creager et al. published in AHA/ASA Journals:
“New 2026 AHA/ACC Guideline for Acute Pulmonary Embolism
A major, multidisciplinary update on how we evaluate, risk stratify, and manage PE has just been published in Circulation Journal.
After going through the document, a few themes stand out that will meaningfully impact day-to-day practice:
- A New PE Classification (A-E)
The guideline introduces an AHA/ACC Acute PE Clinical Category system (A-E), moving beyond the traditional ‘massive vs submassive’ framework. This aligns PE care with modern shock and heart failure paradigms, and importantly recognizes entities like ‘shock without hypotension’. - Smarter, More Efficient Diagnostics
Strong emphasis on Age-adjusted D-dimer and YEARS algorithm to safely avoid unnecessary imaging. - Anticoagulation Remains the Foundation
Clear recommendation: LMWH preferred over UFH when parenteral therapy is needed (unless instability or procedures expected). - PERT Becomes Central to Care
Strong recommendation for Pulmonary Embolism Response Teams (PERT). PERT activation is now recommended for Categories C-E. Think CODE PE similar to CODE STEMI. - A Paradigm Shift in Advanced Therapy
An important shift in the 2026 AHA/ACC PE guideline is how we think about advanced therapy. It’s no longer simply: ‘Remove the clot’. It’s: Preserve and recover RV function
For those of us in Emergency Medicine and Thrombosis, this will shape how we triage, treat, and follow PE patients moving forward.”
Title: 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Authors: Mark Creager, Geoffrey Barnes, Jay Giri, Debabrata Mukherjee, William Jones, Allison Burnett, Teresa Carman, Ana Casanegra, Lana Castellucci, Sherrell Clark, Mary Cushman, Kerstin de Wit, Jennifer Eaves, Margaret Fang, Joshua Goldberg, Stanislav Henkin, Hillary Johnston-Cox, Sabeeda Kadavath, Daniella Kadian-Dodov, William Keeling, Andrew Klein, Jun Li, Michael McDaniel, Lisa Moores, Gregory Piazza, Karen Prenger, Steven Pugliese, Mona Ranade, Rachel Rosovsky, Farla Russo, Eric Secemsky, Akhilesh Sista, Leben Tefera, Ido Weinberg, Lauren Westafer, Michael Young
Read the Full Guideline on AHA/ASA Journals․

Stay updated on all scientific advances with Hemostasis Today.
-
Sep 1, 2026, 17:33Getnet Tarekegn: Comparing Oral Iron Preparations in Pediatric Iron Deficiency Anemia
-
Sep 1, 2026, 17:30Does Platelet FcγRIIA Really Amplify Thrombosis on Its Own? – RPTH Journal
-
Sep 1, 2026, 17:26EAHAD 2027 Abstract Submissions Are Now Open
-
Sep 1, 2026, 17:16Susan Shea։ VWF A1 Blockade Emerges as a Novel Strategy for Arterial Thrombosis
-
Sep 1, 2026, 17:04Hugo R Lara-Martinez: Recognizing HLH After Immune Checkpoint Inhibitor Therapy
-
Sep 1, 2026, 16:50Heghine Khachatryan: When to Test for Thrombophilia After VTE
-
Sep 1, 2026, 16:41Axel Diederichsen: Can Vitamin K2 and Vitamin D3 Slow the Progression of Severe Coronary Artery Calcification?
-
Sep 1, 2026, 16:15Sangeeta Pathak: The Bombay Blood Group as a Very Rare Phenotype
-
Sep 1, 2026, 16:14The Ecuador 2026 National Conference on Coagulation Disorders – WFH